H. Cramer

1.6k total citations
82 papers, 1.3k citations indexed

About

H. Cramer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, H. Cramer has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 14 papers in Physiology. Recurrent topics in H. Cramer's work include Neurological disorders and treatments (10 papers), DNA and Nucleic Acid Chemistry (9 papers) and Neuroscience and Neuropharmacology Research (8 papers). H. Cramer is often cited by papers focused on Neurological disorders and treatments (10 papers), DNA and Nucleic Acid Chemistry (9 papers) and Neuroscience and Neuropharmacology Research (8 papers). H. Cramer collaborates with scholars based in Germany, United States and France. H. Cramer's co-authors include Koichi Murata, Paul Bach‐y‐Rita, Klaus Rißler, Toni Lindl, James L. Rudolph, D. Strubel, J. Kohler, Paul F. Torrence, Robert H. Silverman and Bernard Renaud and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Trends in Neurosciences.

In The Last Decade

H. Cramer

79 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H. Cramer 512 378 217 176 159 82 1.3k
Françoise Saurini 461 0.9× 556 1.5× 212 1.0× 114 0.6× 171 1.1× 23 1.7k
Kazuo Kato 378 0.7× 412 1.1× 168 0.8× 197 1.1× 78 0.5× 82 1.5k
Miguel Angel López-González 389 0.8× 197 0.5× 177 0.8× 100 0.6× 341 2.1× 82 1.6k
Horacio E. Romeo 287 0.6× 303 0.8× 191 0.9× 89 0.5× 120 0.8× 50 1.2k
H. Feistner 290 0.6× 288 0.8× 147 0.7× 206 1.2× 44 0.3× 52 1.4k
Leopold Liss 319 0.6× 202 0.5× 249 1.1× 98 0.6× 112 0.7× 64 1.2k
Lawrence Z. Stern 719 1.4× 612 1.6× 277 1.3× 186 1.1× 134 0.8× 70 1.9k
Frida Loría 422 0.8× 595 1.6× 336 1.5× 140 0.8× 58 0.4× 28 1.9k
Lidia Yshii 273 0.5× 174 0.5× 214 1.0× 95 0.5× 77 0.5× 33 1.1k

Countries citing papers authored by H. Cramer

Since Specialization
Citations

This map shows the geographic impact of H. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Cramer more than expected).

Fields of papers citing papers by H. Cramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Cramer. The network helps show where H. Cramer may publish in the future.

Co-authorship network of co-authors of H. Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Cramer. A scholar is included among the top collaborators of H. Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Cramer. H. Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Paranjape, Jayashree M., Da Xu, David Kushner, et al.. (2006). Human Telomerase RNA Degradation by 2'-5'-Linked Oligoadenylate Antisense Chimeras in a Cell-Free System, Cultured Tumor Cells, and Murine Xenograft Models. Oligonucleotides. 16(3). 225–238. 3 indexed citations
3.
Cramer, H., et al.. (2003). The Use of Triisopropylsilyl-oxymethyl (TOM) in the Synthesis of Anti-telomerase 2-5A Antisense Compound RBI 011. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1733–1736. 2 indexed citations
4.
Xu, Zan, et al.. (2003). Potent inhibition of respiratory syncytial virus by combination treatment with 2–5A antisense and ribavirin. Antiviral Research. 61(3). 195–206. 20 indexed citations
5.
Leaman, Douglas W., et al.. (2002). Targeted Therapy of Respiratory Syncytial Virus in African Green Monkeys by Intranasally Administered 2-5A Antisense. Virology. 292(1). 70–77. 31 indexed citations
6.
Adah, Steven A., et al.. (2001). Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy. Current Medicinal Chemistry. 8(10). 1189–1212. 27 indexed citations
7.
Cramer, H. & Wolfgang Pfleiderer. (2000). Nucleotides LXIV[1]: Synthesis, Hybridization and Enzymatic Degradation Studies of 2′-O-Methyl-Oligoribonucleotides and 2′-O-Methyl/Deoxy Gapmers. Nucleosides Nucleotides & Nucleic Acids. 19(10-12). 1765–1777. 9 indexed citations
8.
Geselowitz, Daniel A., H. Cramer, Ewald M. Wondrak, Mark R. Player, & Paul F. Torrence. (2000). Fluorescence Resonance Energy Transfer Analysis of RNase L-Catalyzed Oligonucleotide Cleavage. Antisense and Nucleic Acid Drug Development. 10(1). 45–51. 6 indexed citations
9.
Kushner, David, Jayashree M. Paranjape, Bhaswati Bandyopadhyay, et al.. (2000). 2-5A Antisense Directed against Telomerase RNA Produces Apoptosis in Ovarian Cancer Cells. Gynecologic Oncology. 76(2). 183–192. 63 indexed citations
10.
Cramer, H., Daniel A. Geselowitz, & Paul F. Torrence. (1999). Using Fluorescence Resonance Energy Transfer (FRET) for Measuring 2-5A Analogues Ability to Activate RNase L. Nucleosides and Nucleotides. 18(6-7). 1523–1525. 1 indexed citations
11.
Torrence, Paul F., et al.. (1997). Recruiting the 2-5A System for Antisense Therapeutics. Antisense and Nucleic Acid Drug Development. 7(3). 203–206. 26 indexed citations
12.
Strittmatter, M., et al.. (1997). Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. Biological Psychiatry. 41(11). 1124–1130. 11 indexed citations
13.
Strittmatter, M., Gerhard F. Hamann, Markus T. Grauer, H. Cramer, & К. Schimrigk. (1996). Neurochemical Differences in the CSF between Binswanger's and Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 8(1). 34–42. 2 indexed citations
14.
Moser, Andréas & H. Cramer. (1992). Peptidergic modulation of G-protein coupled cyclic-AMP accumulation in the rat caudate nucleus. Neuropeptides. 22(3). 143–147. 1 indexed citations
15.
Cramer, H., et al.. (1991). Ventricular fluid neuropeptides in Parkinson's disease. II. Levels of substance P-like immunoreactivity. Neuropeptides. 18(2). 69–73. 12 indexed citations
16.
17.
Masson, Hélène, et al.. (1990). Somatostatin‐Like Immunoreactivity in the Cerebrospinal Fluid of Aged Patients with Parkinson's Disease. Journal of the American Geriatrics Society. 38(1). 19–24. 8 indexed citations
18.
Cramer, H., et al.. (1987). Somatostatin-like immunoreactivity in cerebroventricular fluid of patients with basal midline tumours. Neurological Research. 9(3). 205–210. 1 indexed citations
19.
Lindl, Toni, et al.. (1976). Effects of compound 48/80, a histamine-releasing agent, on accumulation and release of cyclic AMP in various regions of rat brain in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(1). 65–74. 2 indexed citations
20.
Květňanský, Richard, et al.. (1971). Immobilization Stress Induced Changes in Adrenocortical and Medullary Cyclic AMP Content in the Rat. Endocrinology. 88(2). 338–344. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Françoise Saurini Breakdown of academic impact, for papers by Kazuo Kato Breakdown of academic impact, for papers by Miguel Angel López-González Breakdown of academic impact, for papers by Horacio E. Romeo Breakdown of academic impact, for papers by H. Feistner Breakdown of academic impact, for papers by Leopold Liss Breakdown of academic impact, for papers by Lawrence Z. Stern Breakdown of academic impact, for papers by Frida Loría Breakdown of academic impact, for papers by Lidia Yshii
Rankless by CCL
2026